Physician profile
James Lynch
NPI 1205327608
$7,788.76
in general payments reported to CMS, 2019-2025
18 companies · $2,517 in 2025
The $2,517 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.51 · 2020: $24.86 · 2022: $92.76 · 2023: $343 · 2024: $4,716 · 2025: $2,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,575.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,820.70 | 2023-2025 | Da Vinci Surgical System |
| Abbott Laboratories | $183.96 | 2023 | Octrode |
| Biogen, INC. | $131.03 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $104.28 | 2019-2023 | |
| Hologic Sales and Service, LLC | $69.20 | 2023-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Medtronic, INC. | $66.63 | 2022-2024 | Truclear |
| Mayne Pharma Commercial LLC | $49.21 | 2025 | |
| Organon LLC | $49.01 | 2023-2024 | Nexplanon |
| Millicent US INC | $48.13 | 2025 | Femlyv |
| Coopersurgical, INC. | $46.84 | 2024-2025 | Ally II Ups, Paragard T 380a, Sos |
| Aspira Women'S Health INC | $46.25 | 2022 | |
| Exeltis, USA INC. | $42.61 | 2024-2025 | Slynd |
| Caldera Medical, INC | $40.30 | 2025 | |
| Amag Pharmaceuticals, INC. | $22.65 | 2019 | |
| Astellas Pharma US INC | $21.21 | 2025 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.36 | 2019 | |
| Pfizer INC. | $15.42 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.